Lu, C., Xu, C., Li, S., Ni, H., & Yang, J. Liraglutide and GLP-1(9–37) alleviated hepatic ischemia-reperfusion injury by inhibiting ferroptosis via GSK3β/Nrf2 pathway and SMAD159/Hepcidin/FTH pathway. Elsevier.
Chicago Style (17th ed.) CitationLu, Chenqi, Cong Xu, Shanglin Li, Haiqiang Ni, and Jun Yang. Liraglutide and GLP-1(9–37) Alleviated Hepatic Ischemia-reperfusion Injury by Inhibiting Ferroptosis via GSK3β/Nrf2 Pathway and SMAD159/Hepcidin/FTH Pathway. Elsevier.
MLA (9th ed.) CitationLu, Chenqi, et al. Liraglutide and GLP-1(9–37) Alleviated Hepatic Ischemia-reperfusion Injury by Inhibiting Ferroptosis via GSK3β/Nrf2 Pathway and SMAD159/Hepcidin/FTH Pathway. Elsevier.
Warning: These citations may not always be 100% accurate.